TP53 mutations
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
TP53 mutations
Jun 2, 2024, 00:01 |
Blog
Iván R. González: A recent study has revealed crucial molecular features in phyllodes tumors of the breast
Iván R. González, Medical Oncologist at Comprehensive Oncology Center, Hospital Ángeles Puebla, shared a post…
May 29, 2024, 04:59 |
Blog
Estela Rodriguez: Patients excluded from most clinical trials does not help us find solutions with Leptomeningeal disease
Estela Rodriguez shared a post by EGFR Resisters on X/Twitter: "Leptomeningeal disease - is one of…
May 26, 2024, 03:42 |
Insight
UCLA: Large precision oncology study identifies differences in prostate cancer genomics among a racially and ethnically diverse cohort of U.S. veterans
Genomic study of veterans with advanced prostate cancer reveals differences in frequencies of alterations and…
May 18, 2024, 03:23 |
Insight
Myeloma Paper of the Day, May 17th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Single cell multi-omic ATAC- and…
Apr 17, 2024, 00:22 |
Insight
Jeffrey Lee: Very important work from Banu Arun, Weniy Wang and their team for developing new risk prediction models for Li-Fraumeni syndrome
Jeffrey Lee, Chief Cancer Network Officer and Deputy Chief Operating Officer at MD Anderson Cancer…
All:
5
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube